Evidence for a role of advanced glycation end products in atrial fibrillation

International Journal of Cardiology

Volumn 157, Issue 3, 2012, Pages 397-402

  Raposeiras Roubín, Sergio ^a   Rodiño Janeiro, Bruno K ^a   Grigorian Shamagian, Lilian ^a,c   Seoane Blanco, Ana ^a   Moure González, María ^a   Varela Román, Alfonso ^a   Álvarez, Ezequiel ^a,b   González Juanatey, José R ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c HOSPITAL DO MEIXOEIRO   (Spain)

Author keywords

Advanced glycation end products (AGEs); Atrial fibrillation; Left atrial remodelling; Oxidative stress; Soluble receptor for AGE (sRAGE)

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR;

AGED; ARTICLE; DIABETES MELLITUS; DISEASE MARKER; FEMALE; FLUORESCENCE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED, 80 AND OVER; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MIDDLE AGED;

EID: 84861233867     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.05.072     Document Type: Article

References (22)

1. R.H. Falk Atrial fibrillation N Engl J Med 344 2001 1067 1078
2. S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 2002 219 226
3. M. Schmidt, H. Marschang, and S. Clifford Trends in inflammatory biomarkers during atrial fibrillation ablation across different catheter ablation strategies Int J Cardiol 2011 10.1016/j.ijcard.2010.12.084
4. B. Burstein, and S. Nattel Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation J Am Coll Cardiol 51 2008 802 809
5. M.R. Movahed, M. Hashemzadeh, and M.M. Jamal Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease Int J Cardiol 105 2005 315 318
6. E. Selvin, M.W. Steffes, and H. Zhu Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults N Engl J Med 362 2010 800 811
7. T. Nishikawa, D. Edelstein, and X.L. Du Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage Nature 404 2000 787 790
8. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
9. J.W. Hartog, A.A. Voors, S.J. Bakker, A.J. Smit, and D.J. van Veldhuisen Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications Eur J Heart Fail 9 2007 1146 1155
10. F. Fiordaliso, I. Cuccovillo, and R. Bianchi Cardiovascular oxidative stress is reduced by an ACE inhibitor in a rat model of streptozotocin-induced diabetes Life Sci 79 2006 121 129
11. S. Yamagishi, H. Adachi, and K. Nakamura Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects Metabolism 55 2006 1227 1231
12. T. Kato, T. Yamashita, and A. Sekiguchi AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat J Cardiovasc Electrophysiol 19 2008 415 420
13. L. van Heerebeek, N. Hamdani, and M.L. Handoko Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension Circulation 117 2008 43 51
14. M.A. Hofmann, S. Drury, and C. Fu RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides Cell 97 1999 889 901
15. C.J. Boos, and G.Y. Lip Inflammation and atrial fibrillation: cause or effect? Heart 94 2008 133 134
16. R.K. Wong, A.I. Pettit, P.A. Quinn, S.C. Jennings, J.E. Davies, and L.L. Ng Advanced glycation end products stimulate an enhanced neutrophil respiratory burst mediated through the activation of cytosolic phospholipase A2 and generation of arachidonic acid Circulation 108 2003 1858 1864
17. Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1 2010 S62 S69
18. S. Raposeiras-Roubín, B.K. Rodino-Janeiro, and L. Grigorian Shamagian Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels Eur J Heart Fail 12 2010 1092 1100
19. G. Munch, R. Keis, and A. Wessels Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA Eur J Clin Chem Clin Biochem 35 1997 669 677
20. R. Mukherjee, A.R. Herron, and A.S. Lowry Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation Am J Cardiol 97 2006 532 537
21. Y. Nakano, S. Niida, and K. Dote Matrix metalloproteinase-9 contributes to human atrial remodeling during atrial fibrillation J Am Coll Cardiol 43 2004 818 825
22. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2